Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and indirubin

cyc 202 has been researched along with indirubin in 3 studies

Compound Research Comparison

Studies
(cyc 202)		Trials
(cyc 202)		Recent Studies (post-2010)
(cyc 202)		Studies
(indirubin)		Trials
(indirubin)		Recent Studies (post-2010) (indirubin)
97973933473184

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)indirubin (IC50)
Glycogen synthase kinase-3 beta Sus scrofa (pig)1
[Tau protein] kinase Sus scrofa (pig)1
Cyclin-dependent kinase 14Homo sapiens (human)2.2
G2/mitotic-specific cyclin-B2Homo sapiens (human)8.25
Epidermal growth factor receptorHomo sapiens (human)2
Insulin receptorHomo sapiens (human)2
Cyclin-dependent kinase 1Homo sapiens (human)7.74
Cyclin-dependent kinase 4Homo sapiens (human)2.2
G2/mitotic-specific cyclin-B1Homo sapiens (human)8.8333
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)1
Cyclin-A2Homo sapiens (human)3.525
Cyclin-dependent kinase 11BHomo sapiens (human)2.2
Kit ligandHomo sapiens (human)2
G1/S-specific cyclin-E1Homo sapiens (human)4.85
Cyclin-dependent kinase 2Homo sapiens (human)3.24
Vascular endothelial growth factor receptor 2Homo sapiens (human)2
Cyclin-dependent kinase 8Homo sapiens (human)2.2
Glycogen synthase kinase-3 alphaHomo sapiens (human)1.5
Glycogen synthase kinase-3 betaHomo sapiens (human)0.8515
Cyclin-dependent kinase 7Homo sapiens (human)2.2
Cyclin-dependent kinase 9Homo sapiens (human)2.2
Cyclin-dependent kinase 3Homo sapiens (human)2.2
Cyclin-dependent kinase 6Homo sapiens (human)2.2
Cyclin-dependent-like kinase 5 Homo sapiens (human)6.15
Cyclin-dependent kinase 16Homo sapiens (human)2.2
Cyclin-dependent kinase 17Homo sapiens (human)2.2
Cyclin-dependent kinase 18Homo sapiens (human)2.2
Cyclin-dependent kinase 13Homo sapiens (human)2.2
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)6.7143
Cyclin-dependent kinase 10Homo sapiens (human)2.2
Cyclin-dependent kinase 20Homo sapiens (human)2.2
G2/mitotic-specific cyclin-B3Homo sapiens (human)8.25
Cyclin-dependent kinase 15Homo sapiens (human)2.2
Cyclin-dependent kinase 19Homo sapiens (human)2.2
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)1
Cyclin-dependent kinase 12Homo sapiens (human)2.2

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cheng, X; Christ, J; Eisenbrand, G; Merz, KH; Muehlbeyer, S; Thommet, A; Vatter, S; Wölfl, S; Zeller, J1
Li, J; Liang, C; Liu, C; Qiang, T; Ren, X; Shi, Z; Tian, L; Xing, Y1
Aoun, J; Bengrine-Lefèvre, L; Carassou, P; Le Moulec, S; Meijer, L1

Reviews

2 review(s) available for cyc 202 and indirubin

ArticleYear
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.
    Journal of medicinal chemistry, 2022, 05-12, Volume: 65, Issue:9

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; Female; Humans; Pharmaceutical Preparations; Protein Kinase Inhibitors

2022
[Cell cycle and molecular targets: CDK inhibition].
    Bulletin du cancer, 2012, Feb-01, Volume: 99, Issue:2

    Topics: Animals; Cell Cycle; Cyclin-Dependent Kinases; Humans; Indoles; Mice; Mice, Knockout; Phosphorylation; Protein Kinase Inhibitors; Proteins; Purines; Roscovitine; Structure-Activity Relationship

2012

Other Studies

1 other study(ies) available for cyc 202 and indirubin

ArticleYear
Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.
    Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Screening Assays, Antitumor; Humans; Indoles; Oximes; Protein Kinase Inhibitors; Receptor, IGF Type 1; Signal Transduction; Solubility; Structure-Activity Relationship

2017